Alzheimer's disease, a type of dementia that profoundly alters a person’s memory and cognitive function, affects an estimated 6.7 million U.S. adults at least 65 years old, according to the ...

Researchers say CSF biomarker test correlates with the severity of cognitive decline, independent of other factors, including brain amyloid deposition.

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the University of Pittsburgh School of Medicine can detect small amounts of the ...

Neurofibrillary tangles (NFTs) are a hallmark of Alzheimer’s disease, formed by the accumulation of tau protein into ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

A new biomarker test developed at the University of Pittsburgh could help doctors doctors detect signs of Alzheimer's years sooner, according to research published Monday in Nature Medicine.

advanced coverage for beta-amyloid PET imaging by removing coverage with evidence development (CED), allowing Medicare to cover amyloid PET scans outside of a research protocol. Change begins with ...

A new biomarker test identifies very early stages of tau tangle formation, up to a decade before any tau clumps can show up ...